We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Technology 4 Venture Capital Trust Plc | LSE:OXF | London | Ordinary Share | GB00B01H4V84 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMOXF 26 May 2016 Oxford Technology 4 VCT plc ("the Company" or "OT4") Annual Report and Accounts for the year ended 29 February 2016 The Directors are pleased to announce the audited results of the Company for the year ended 29 February 2016 and a copy of the Annual Report and Accounts ("Accounts") will be made available to Shareholders shortly. Set out below are extracts of the audited Accounts. References to page numbers below are to those Accounts. The AGM will be held at The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA on Friday 8 July 2016, at 11am. A copy of the Annual Report and Accounts will be available from the registered office of the Company at The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA, as well as on the Company's website: www.oxfordtechnology.com Financial Headlines Year Ended Year Ended 29 February 2016 28 February 2015 Net Assets at Year End GBP7.69m GBP7.63m Net Asset Value per Share 66.8p 66.2p Cumulative Dividend 37.0p 17.0p NAV + Cumulative Dividend Paid from Incorporation 103.8p 83.2p Share Price at Year End 52.0p 36.5p Earnings Per Share (Basic & Diluted) 20.6p (3.1)p Chairman's Statement I am pleased to present to shareholders the annual report for the year to 29 February 2016. Overview There have been substantial changes within the portfolio during the year. Two companies were realised, and two companies failed. Several other companies have achieved significant milestones which should enhance value. Net asset value rose by a modest 0.6p during the year, although total return rose by 20.6p. Portfolio Review The net asset value per share on 29 February 2016 was 66.8p compared to 66.2p on 28 February 2015. Two dividends of 10p per share were paid in the year on 7 August 2015 and 19 February 2016. Total dividends paid are now 37p per share. Earnings per share in the year to 29 February 2016 were 20.6p. Total return as of 29 February 2016 stands at 103.8p. The Company's portfolio still contains 19 holdings, which continue to develop at different rates. Whilst not all may ultimately be successful, some are reaching significant value inflection points which allows realisations to occur. Two portfolio companies were realised in the year. In May 2015 Impact Applications was sold to AIM listed Castleton Technology Plc, and in November Telegesis was sold to Silicon Laboratories UK Ltd. However, two companies also failed. Oxtox reached a point where their technology was unable to match the technical performance required by the market, and MirriAd was unable to close a funding round. The MirriAd technology has been acquired by MirriAd Advertising, in which your company now has a holding. Your company continues to invest in support of its portfolio as companies develop. A further GBP200,000 has been invested into ImmBio to support the first in Human trial for its novel Pneumococcal Vaccine, PnuBioVax. The trial began in December 2015, and read out is expected in Q2 2016. If successful, this will be an extremely important milestone for the company. Further investments were also made into Dynamic Extractions, Orthogem and ZuvaSyntha to support their growth. Further details on the other major investments are contained within the Investment Manager's Portfolio Review, and on our website. Last year, we flagged that we were assessing the opportunity for divestments so as to crystallise shareholder value as and when appropriate, and were delighted to announce the sale of Telegesis and Impact Applications. Whilst we continue to seek opportune moments to maximise value from our portfolio, we do not currently foresee any further major liquidity events in the near future. Dividends The ongoing strategy is to seek to crystallise value from the portfolio and distribute cash to shareholders via dividend payments. As already stated, dividends totalling 20p were paid during the year. Management and Performance Fees Shareholders will recall the changes announced during the year at the time of the announcement of the 2015 results. Management fees were reduced to 1% per annum with effect from the start of this financial year, with an annual cost cap of 3% (excluding directors' fees) to cover all of the running costs incurred by the VCT. The threshold at which a performance fee would also become payable escalates at 6% per annum from the 10th anniversary of the formation of the VCT. The threshold therefore now stands at a return to shareholders in cash of 104.7p per share. No payment has been made to date under this scheme. Your directors continue to believe that this lower level of management fees, together with a performance fee incorporating a challenging hurdle and payable only once shareholders have received back more than their original investment prior to any additional tax reliefs, makes this management arrangement market-leading and continues the principle always adopted by the VCT to keep its costs as low as possible. Board Structure and VCT Management Lucius Cary did not stand for re-election as a Director at the AGM in 2015. He does however remain involved in the management of the VCT through Oxford Technology Management. Shareholders will also be aware of the changes to the Board and Management arrangements that were implemented during the year, implementing a Common Board across the four Oxford Technology VCTs to coincide with the companies becoming 'self-managed'. I welcome Richard Roth, Alex Starling and Robin Goodfellow to the Board. Lucius Cary and his team continue to be involved with the portfolio as OT4 Managers Ltd (the Company's investment manager) sub-contracts services from Oxford Technology Management. The new Common Board structure has worked well since implementation. VCT Regulation Changes Shareholders may be aware of some significant changes to the VCT rules that have been introduced during the year. These changes have been introduced by the UK Government, but were directed by the EU to make VCTs conform to "State Aid" rules. The rules introduce new restrictions on the type of investments which can be made by VCTs, specifically prohibiting VCT funds from being used to finance management buy-outs or for the acquisition of existing businesses. The rules also impose a maximum lifetime amount a company can receive from VCTs, as well as imposing a maximum age for companies which receive VCT funding. The new restrictions, which apply to non-qualifying holdings as well as VCT qualifying holdings, took effect for investments made on or after 18 November 2015. The potential penalty for breach of these regulations is withdrawal of VCT status. The new legislation is designed to target more VCT money towards the sorts of companies that OT4 has always invested in, and is not expected to have a significant effect on your Company. The Directors will remain alert to the additional requirements of these latest rules with any further investments OT4 may make. Change of Registrar As part of our ongoing focus on costs, we appointed Neville Registrars in place of Capita as our Registrars. Details of the new contact details are set out on the back page of this report. We would also remind you that Annual Reports, notices of shareholder meetings and other documents that are required to be sent to Shareholders are published on our website at www.oxfordtechnology.com/vct4, as well as any other announcements made by the Company. Share Buy Backs The Company has the ability to buy back shares. To date this authority has never been exercised and the Directors have no current intention to do so, preferring instead to preserve resources to support our investees and pay dividends to all shareholders. It is, however, a useful facility to have available should circumstances change and the Company therefore wishes to maintain this capability. At the AGM, Shareholders will be asked to confirm their ongoing approval for the Company to be able to buy back its own shares. AGM Shareholders should note that the AGM for the Company will be held on Friday 8 July 2016 at the Magdalen Centre, Oxford Science Park, starting at 11am and will include presentations by Oxford Technology Management and some of the companies in which the Oxford Technology VCTs have invested. A formal Notice of the AGM has been enclosed with these Financial Statements together with a Form of Proxy for those not attending. We appreciate the input of our shareholders and look forward to welcoming as many of you as possible on the day. Outlook The Board's outlook has not changed from a year ago. The portfolio continues to develop, and individual investments will be realised at appropriate times. In 2015, we realised two investments with what appears to have been excellent timing, providing the ability to continue supporting the remaining portfolio and to pay dividends. We continue to work to maximise value for shareholders and will, as per our stated strategy, seek to crystallise this value and distribute to shareholders via dividend payments when valuations and liquidity allow. David Livesley Chairman 25 May 2016 Investment Portfolio Review OT4 was formed in 2004 and has invested in 35 companies which were start-up or early stage technology companies. Some of these companies failed with the loss of the investment. Some have succeeded and have been sold. The table on page 12 shows the companies remaining in the
portfolio. A more detailed analysis is given of the top 5 investments. One of the investees was Impact Applications which was sold to Castleton Technology Plc in May 2015. OT4's investment of GBP486,000 yielded an immediate cash payment of GBP1.6m to the fund and shares in AIM listed Castleton Technology Plc worth an additional GBP1.1m at the time of the acquisition. A small portion of these were subsequently sold yielding an additional GBP86k. A dividend of 10p per ordinary share was paid in July 2015 as a result of this exit. A second dividend of 10p per ordinary share was paid in February 2016 following the sale of Telegesis, bringing the cumulative dividends paid to date to 37p. OT4 first invested in Telegesis in 2005, following on from OT3's first investment when the company started in 2003. Telegesis specialised exclusively in Zigbee, a strategy which proved to be very successful. When large companies wish to incorporate Zigbee communications (for example to enable smart electricity meters to send and receive data wirelessly) they frequently turned to Telegesis to do the detailed design and then to supply the Zigbee modules, which were manufactured in China. In November 2015, Telegesis was sold for GBP13m to Silicon Laboratories UK. OT4 received cash proceeds of GBP1.62m for its shares. In February 2016 Select Technology paid out its first dividend following the cessation of its printer manufacturing activities (a strategic withdrawal from a difficult market that took place around the time of the recent economic downturn). Select Technology is now solely an international master distributor of its own and third party software. The management team at Select Technology is busy implementing a growth strategy with a view to further establishing itself as a key player in its markets. The portfolio contains several other investees which are showing promise and which have the potential to deliver significant returns. New Investments in the year There were four follow on investments during the year of GBP200,000 into ImmBio, GBP20,000 into Orthogem, GBP225,000 into ZuvaSyntha and GBP200,000 into Dynamic Extractions. All new investments have complied with both EU State Aid rules and HMRC VCT rules. Disposals during the year There have been several disposals during this year. Impact Applications was sold in May yielding GBP1.59m to the fund with shares in Castleton Technology Plc as part of the deal, initially worth GBP1.1m, but valued at GBP1.8m on 29 February 2016. Telegesis was also sold during the year and OT4 received GBP1.62m from its investment of GBP231,000. Some Abzena shares were sold yielding GBP21,657 and the final tranche of payments from the sale of Imagineer Systems were received for GBP16,139. OxTox Ltd was also sold to Alcolizer for GBP11,533. Valuation Methodology Quoted and unquoted investments are valued in accordance with current industry guidelines that are compliant with International Private Equity and Venture Capital Valuation Guidelines and current financial reporting standards. VCT Compliance Compliance with the main VCT regulations as at 29 February 2016 and for the year then ended is summarised as follows: Type of Investment By HMRC Valuation Rules Actual Target Minimum obligation of: VCT Qualifying Investments 92.6% 70.0% Maximum allowed: Non-Qualifying Investments 7.4% 30.0% Total 100.0% 100.0% At least 10% of each investment in a qualifying company is held in 'eligible shares' - Complied. No more than 15% of the income from shares and securities is retained - Complied. No investment constitutes more than 15% of the Company's portfolio (by value at time of investment) - Complied. No investment made by the VCT has caused the company to receive more than GBP5m of State Aid investment in the year - Complied. Table of Investments held by Company at 29 February 2016 Change in Carrying value value at for the Net cost of 29/02/16 year % equity held by Company Description Date of initial investment investment GBP'000 GBP'000 GBP'000 OT4 Mobile software Castleton Technology for Quoted on AIM contractors Oct 2005 192 1,811 1,811 2.9 Needle free Glide Technologies injectors Feb 2005 975 1,439 - 5.8 Photocopier Select Technology Interfaces Aug 2006 237 941 355 18.4 Protein Arecor stabilization Jul 2007 291 445 - 6.2 Solid state Plasma Antennas antennas Mar 2005 448 427 (149) 24.9 Diamond Diamond Hard Surfaces coatings Jan 2005 640 385 - 49.9 ImmBio Novel vaccines Oct 2005 575 351 200 7.7 Separation Dynamic Extractions technology Aug 2005 377 313 200 23.8 Rechargeable Oxis Energy batteries Nov 2005 305 150 - 0.3 Microbial ZuvaSyntha technology Feb 2012 313 91 (7) 19.8 Bioengineering and Novacta antibiotics Apr 2005 347 63 - 2.4 Active wound healing Insense dressings Apr 2005 476 48 - 4.5 Abzena Protein based Quoted on AIM peptide drugs Jan 2012 33 48 (52) 0.1 Bone graft Orthogem material May 2007 130 35 20 3.3 Traceability Historic Futures software Aug 2005 420 32 - 6.2 Virtual product MirriAd Advertising placement May 2015 0 15 15 0.3 Business Naked Objects software Mar 2006 200 10 (1) 22.2 Production of Metal Nanopowders nanopowders Aug 2006 51 10 - 16.7 Very hard Superhard Materials materials Feb 2012 9 5 (4) 18.2 Totals 6,019 6,619 2,386 Other Net Assets 1,074 NET ASSETS 7,693 Number of shares in issue: 11,516,946 Net Asset Value per share at 29 February 2016: 66.8p Dividends paid to date: 37.0p The table shows the current portfolio holdings. The investments in Bluewater Bio, Cutting the Wires, Dynamic Discovery, EKB, Ingenious, Inspiration Matters, Kinomi, MirriAd and Water Innovate have been written off. The investments in Dexela, Imagineer Systems, Impact Applications, Incentec, Mecira, OxTox, Pharma Engineering, Telegesis and Warwick Effect Polymers have been sold. Some shares in Abzena and Castleton have also been sold. Directors' Report The Directors present their report together with financial statements for the year ended 29 February 2016. This report has been prepared by the Directors in accordance with the requirements of s415 of the Companies Act 2006. The Company's independent auditor is required by law to report on whether the information given in the Directors' Report is consistent with the financial statements. Principal Activity The Company commenced business in 2004. The Company invests in start-up and early stage technology companies in general located within 60 miles of Oxford. The Company has maintained its approved status as a Venture Capital Trust by HMRC. Directors The Directors of the Company are required to notify their interests under Disclosure and Transparency Rule 3.12R. The present and previous membership of the board and their beneficial interests in the ordinary shares of the company at 29 February 2016 and at 28 February 2015 are set out below: Name 2016 2015
D Livesley 3,499 3,499 R Goodfellow* 20,000 N/A R Roth* 44,310 N/A A Starling * Nil N/A L Cary** N/A 55,661 * Appointed 3 July 2015 At 3 July 2015, the date of Robin Goodfellow's appointment he held no shares in OT4. At 3 July 2015, the date of Richard Roth's appointment he held 44,310 shares in OT4. ** Resigned 26 August 2015 Under the Company's Articles of Association one third of the Directors are required to retire by rotation each year. David Livesley and Alex Starling will be nominated for re-appointment at the forthcoming AGM. The Board believes that both non-executive Directors continue to provide a valuable contribution to the Company and remain committed to their roles. The Board recommends that Shareholders support the resolutions to re-elect David Livesley and Alex Starling at the forthcoming AGM. The Board is cognisant of shareholders' preference for Directors not to sit on the boards of too many larger companies ("overboarding"). Shareholders will be aware that in July 2015, the Company, along with the other VCTs that were managed by Oxford Technology Management, appointed directors such that the four VCTs each had a Common Board. In addition, Richard Roth has subsequently also become a Director of Hygea VCT plc, a VCT investing in the Med Tech sector which is also self-managed and has a number of investments in common with the Oxford Technology VCTs. Whilst great care is taken to safeguard the interests of the shareholders of each separate company, there is an element of overlap in the workload of each Director across the four OT funds due to the way the VCTs are managed. The Directors note that the workload related to the four OT funds is less than it would be for four totally separate and larger funds, and are satisfied that Richard Roth has the time to focus on the requirements of each OT fund. Investment Management Fees OT4 Managers Ltd, the Company's wholly owned subsidiary, has an agreement to provide investment management services to the Company for a fee of 1% of net assets per annum. David Livesley and Richard Roth, together with Lucius Cary are Directors in OT4 Managers Ltd. Directors' and Officers' Insurance The Company has maintained insurance cover on behalf of the Directors, indemnifying them against certain liabilities which may be incurred by them in relation to their duties as Directors of the Company. Ongoing Review The Board has reviewed and continues to review all aspects of internal governance to mitigate the risk of breaches of VCT rules or company law. Whistleblowing The Board has been informed that the Investment Manager has arrangements in place in accordance with the UK Corporate Governance Code's recommendations by which staff of Oxford Technology Management or the Secretary of the Company may, in confidence, raise concerns within their respective organisations about possible improprieties in matters of financial reporting or other matters. Bribery Act 2010 The Company is committed to carrying out business fairly, honestly and openly. The Investment Manager has established policies and procedures to prevent bribery within its organisation. The Company has adopted a zero tolerance approach to bribery and will not tolerate bribery under any circumstance in any transaction the Company is involved in. The Company has instructed the Investment Manager to adopt the same approach with investee companies. Relations with Shareholders The Company values the views of its shareholders and recognises their interest in the Company. The Company's website provides information on all of the Company's investments, as well as other information of relevance to shareholders (www.oxfordtechnology.com/vct4). Shareholders have the opportunity to meet the Board at the Annual General Meeting. In addition to the formal business of the AGM the Board is available to answer any questions a shareholder may have. The Board is also happy to respond to any written queries made by shareholders during the course of the year and can be contacted at the Company's registered office: The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA. Going Concern After making enquiries, the Directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. For this reason they have adopted the going concern basis in preparing the financial statements. Substantial Shareholders At 29 February 2016, the Company has been notified by Neville Registrars of one investor whose interest exceeds three percent of the Company's issued share capital (Oxfordshire County Council Pension Fund 8.87%). Auditors James Cowper Kreston offer themselves for reappointment in accordance with Section 489 of the Companies Act 2006. On behalf of the Board David Livesley Chairman 25 May 2016 Directors' Remuneration Report Introduction This report has been prepared by the Directors in accordance with the requirements of the Companies Act 2006. The Company's independent auditor, James Cowper Kreston, is required to give its opinion on certain information included in this report. This report includes a statement regarding the Directors' Remuneration Policy. Resolutions to approve the Directors' Remuneration Report will be proposed at the Annual General Meeting on 8 July 2016. The Remuneration Policy was approved at the AGM on 26 August 2015, together with the resolution regarding the Directors' Remuneration Report for the year ended 28 February 2015, on a unanimous show of hands, which reflected overwhelming support amongst proxies submitted. This report sets out the Company's forward-looking Directors' Remuneration Policy and the Annual Remuneration Report which describes how this policy has been applied during the year. Directors' Terms of Appointment The Board consists entirely of non-executive Directors who meet at least four times a year and on other occasions as necessary to deal with important aspects of the Company's affairs. Directors are appointed with the expectation that they will serve for at least three years and are expected to devote the time necessary to perform their duties. All Directors retire at the first general meeting after election and thereafter every third year, with at least one Director standing for election or re-election each year. Re-election will be recommended by the Board but is dependent upon shareholder vote. Directors who have been in office for more than nine years will stand for annual re-election in line with the AIC Code. There are no service contracts in place, but Directors have a letter of appointment. Directors' Remuneration Policy The Board acts as the Remuneration Committee and meets annually to review Directors' pay to ensure it remains appropriate given the need to attract and retain candidates of sufficient calibre and ensure they are able to devote the time necessary to lead the Company in achieving its strategy. The Board has not engaged any third party consultancy services, but did consult with the previous Chairmen, Michael O'Regan of Oxford Technology 2 VCT and Richard Vessey of Oxford Technology 3 VCT when the current levels were determined before the last AGM. The Articles of Association of the company state that the aggregate of the remuneration (by way of fee) of all the Directors shall not exceed GBP50,000 per annum unless otherwise approved by ordinary resolution of the Company. Based on the Company sharing a Common Board with the other Oxford Technology VCT funds the following Directors' fees are payable by the Company; per annum Director Base Fee GBP3,500 Chairman's Supplement GBP2,000 Audit Committee Chairman GBP3,000 Audit Committee Member GBP1,500 David Livesley chairs the Company. Richard Roth chairs the Audit Committee, with Robin Goodfellow as a member of the Committee. As the VCT is self-managed, the Audit Committee carries out a particularly important role for the VCT and has played a greater part in the production of the annual accounts compared to recent years. Fees are currently paid annually. The fees are not specifically related to the Directors' performance, either individually or collectively. No expenses are paid to the Directors. There are no share option schemes or pension schemes in place but Directors are entitled to a share of the carried interest as detailed below. David Livesley and Richard Roth receive no remuneration in respect of their directorships of OT4 Managers Ltd, the Company's Investment Manager. The performance incentive fee is described in the Chairman's Statement. As mentioned there, current Directors are entitled to benefit from any payment made, subject to a formula driven by relative lengths of service. The performance fee becomes payable if a certain cash return threshold to shareholders is exceeded - the excess is then subject to a 20% carry that is distributed to Oxford Technology Management, past Directors and current Directors; the remaining 80% is returned to shareholders. At 29 February 2016 no performance fee was accrued for.
Should any performance fee be payable at the end of the year to 28 February 2017, Alex Starling, Robin Goodfellow, and Richard Roth would each receive 0.15% of any amount over the threshold and David Livesley 1.16%. No performance fee will be payable for the year ending 28 February 2017 unless original shareholders have received back at least 108.7p in cash for each 100p (gross) invested. Relative Spend on Directors' Fees The Company has no employees, so no consultation with employees or comparison measurements with employee remuneration are appropriate. Loss of Office In the event of anyone ceasing to be a Director, for any reason, no loss of office payments will be made. There are no contractual arrangements entitling any Director to any such payment. Directors' Emoluments Directors' Fees Year End 28/02/17 Year End 29/02/16 Year End 28/02/15 (unaudited) (audited) (audited) David Livesley GBP5,500 GBP6,167 GBP7,500 Richard Roth GBP6,500 GBP4,333 - Lucius Cary - GBP1,250 GBP2,500 Robin Goodfellow GBP5,000 GBP3,333 - Alex Starling GBP3,500 GBP2,333 - Total GBP20,500 GBP17,416 GBP10,000 Prior to his appointment as a director of OT4, Richard Roth received an additional one off payment of GBP2,000 in the year to 29 February 2016 as compensation for executive work undertaken in relation to the setting up of the Common Board structure. Income Statement Year Ended Year Ended 29 February 2016 28 February 2015 Note Revenue Capital Total Revenue Capital Total Ref. GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 Gain/(Loss) on disposal of fixed asset investments - 1,049 1,049 - (273) (273) Unrealised gain on valuation of fixed asset investments - 1,355 1,355 - 118 118 Other income 2 94 - 94 8 - 8 Investment management fees 3 (19) (58) (77) - (159) (159) Other expenses 4 (55) - (55) (46) - (46) Return on ordinary activities before tax 20 2,346 2,366 (38) (314) (352) Taxation on return on ordinary activities 5 - - - - - - Return on ordinary activities after tax 20 2,346 2,366 (38) (314) (352) Return on ordinary activities after tax attributable to equity shareholders 20 2,346 2,366 (38) (314) (352) Earnings per share - basic and diluted 6 0.2p 20.4p 20.6p (0.4)p (2.7)p (3.1)p There was no other Comprehensive Income recognised during the year. The 'Total' column of the income statement and statement of comprehensive income is the profit and loss account of the Company, the supplementary revenue and capital return columns have been prepared under guidance published by the Association of Investment Companies. All revenue and capital items in the above statement derive from continuing operations. The accompanying notes are an integral part of the financial statements. The Company has only one class of business and derives its income from investments made in shares and securities and from bank and money market funds. Statement of Changes in Equity Unrealised Profit Share Share Capital & Loss Capital Premium Reserve Reserve Total GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 As at 1 March 2014 1,152 813 496 5,522 7,983 Revenue return on ordinary activities after tax - - - (38) (38) Expenses charged to capital (159) (159) Current period gains on disposal - - (273) (273) Current period gains on fair value of investments - - 118 - 118 Prior years' unrealised gains/losses now realised - - (359) 359 - Balance as at 28 February 2015 1,152 813 255 5,411 7,631 Revenue return on ordinary activities after tax - - - 20 20 Expenses charged to capital (58) (58) Current period gains on disposal - - - 1,049 1,049 Current period gains on fair value of investments - - 1,355 - 1,355 Dividends paid (2,304) (2,304) Prior years' unrealised gains now realised - - (654) 654 - Movement in reserves (Note 11) - - (356) 356 - Balance as at 29 February 2016 1,152 813 600 5,128 7,693 The accompanying notes are an integral part of the financial statements. Balance Sheet Year Ended Year Ended 29 February 2016 28 February 2015 Note Ref. GBP'000 GBP'000 GBP'000 GBP'000 Fixed Asset Investments At Fair Value 7 6,619 6,860 Current Assets Debtors 8 26 158 Cash At Bank 1,111 709 Creditors: Amounts Falling Due Within 1 Year 9 (36) (43) Net Current Assets 1,101 824 Creditors: Amounts Falling Due After 1 Year 9 (27) (53) Net Assets 7,693 7,631 Called Up Equity Share Capital 10 1,152 1,152 Share Premium 813 813 Unrealised Capital Reserve 11 600 255 Profit and Loss Account Reserve 11 5,128 5,411 Total Equity Shareholders' Funds 11 7,693 7,631 Net Asset Value Per Share 66.8p 66.2p The accompanying notes are an integral part of the financial statements. The statements were approved by the Directors and authorised for issue on 25 May 2016 and are signed on their behalf by: David Livesley Chairman Statement of Cash Flows Year Ended Year Ended 29 February 2016 28 February 2015 GBP'000 GBP'000 Cash flows from operating activities Return on ordinary activities before tax 2,366 (352) Adjustments for: (Gain)/loss on disposal of investments (1,049) 273 (Gain) on valuation of investments (1,355) (118) Decrease in debtors 125 309 (Decrease)/increase in creditors (33) 43 Movement in investment debtors and creditors - (167) Inflow/(Outflow) from operating activities 54 (12) Cash flows from investing activities Purchase of investments (645) (209) Disposal of investments 3,297 458 Dividends paid (2,304) - Increase in cash at bank 402 237 Opening cash and cash equivalents 709 472 Cash and cash equivalents at year end 1,111 709 The accompanying notes are an integral part of the financial statements. Notes to the Financial Statements This is the first year in which the financial statements have been prepared under Financial Reporting Standard 102 - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' ('FRS 102'). The main changes are primarily presentational and related to the fixed asset investments' fair value hierarchy, and the primary statements and associated reconciliations. The accounting policies have not materially changed from last year. A review of any required changes to comparative figures has taken place
and it has been deemed that no such restatements are necessary. 1. Principal Accounting Policies Basis of Preparation The financial statements have been prepared under the historical cost convention, except for the measurement at fair value of certain financial instruments, and in accordance with UK Generally Accepted Accounting Practice ("GAAP"), including FRS 102 and with the Companies Act 2006 and the Statement of Recommended Practice (SORP) 'Financial Statements of Investment Trust Companies and Venture Capital Trusts (revised 2014)' issued by the AIC. The principal accounting policies have remained materially unchanged from those set out in the Company's 2015 Annual Report and financial statements. There have been no changes to the measurement of the assets and liabilities as a result of the transition to FRS 102. A summary of the principal accounting policies is set out below. FRS 102 sections 11 and 12 have been adopted with regard to the Company's financial instruments. The Company held all fixed asset investments at fair value through profit or loss. Accordingly, all interest income, fee income, expenses and gains and losses on investments are attributable to assets held at fair value through profit or loss. The most important policies affecting the Company's financial position are those related to investment valuation and require the application of subjective and complex judgements, often as a result of the need to make estimates about the effects of matters that are inherently uncertain and may change in subsequent periods. These are discussed in more detail below. Going Concern After reviewing the Company's forecasts and expectations, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. The Company therefore continues to adopt the going concern basis in preparing its financial statements. Key Judgements and Estimates The preparation of the financial statements requires the Board to make judgements and estimates regarding the application of policies and affecting the reported amounts of assets, liabilities, income and expenses. Estimates and assumptions mainly relate to the fair valuation of the fixed asset investments particularly unquoted investments. Estimates are based on historical experience and other assumptions that are considered reasonable under the circumstances. The estimates and the assumptions are under continuous review with particular attention paid to the carrying value of the investments. Investments are regularly reviewed to ensure that the fair values are appropriately stated. Unquoted investments are valued in accordance with current IPEVC valuation guidelines, although this does rely on subjective estimates such as appropriate sector earnings multiples, forecast results of investee companies, asset values of investee companies and liquidity or marketability of the investments held. Although the Directors believe that the assumptions concerning the business environment and estimate of future cash flows are appropriate, changes in estimates and assumptions could result in changes in the stated values. This could lead to additional changes in fair value in the future. Functional and Presentational Currency The financial statements are presented in Sterling (GBP). The functional currency is also Sterling (GBP). Cash and Cash Equivalents Cash and cash equivalents includes cash in hand, deposits held at call with banks, other short-term highly liquid investments with original maturities of three months or less and also include bank overdrafts. Fixed Asset Investments The Company's principal financial assets are its investments and the policies in relation to those assets are set out below. Purchases and sales of investments are recognised in the financial statements at the date of the transaction (trade date). These investments will be managed and their performance evaluated on a fair value basis and information about them is provided internally on that basis to the Board. Accordingly, as permitted by FRS 102, the investments are measured as being fair value through profit or loss on the basis that they qualify as a group of assets managed, and whose performance is evaluated, on a fair value basis in accordance with a documented investment strategy. The Company's investments are measured at subsequent reporting dates at fair value. In the case of investments quoted on a recognised stock exchange, fair value is established by reference to the closing bid price on the relevant date or the last traded price, depending upon convention of the exchange on which the investment is quoted. In the case of AIM quoted investments this is the closing bid price. In the case of unquoted investments, fair value is established by using measures of value such as the price of recent transactions, earnings multiple, revenue multiple, discounted cash flows and net assets. These are consistent with the International Private Equity and Venture Capital (IPEVC) guidelines which can be found on their website at www.privateequityvaluation.com. Gains and losses arising from changes in fair value of investments are recognised as part of the capital return within the Income Statement and allocated to the unrealised capital reserve. In the preparation of the valuations of assets the Directors are required to make judgements and estimates that are reasonable and incorporate their knowledge of the performance of the investee companies. Fair Value Hierarchy Paragraph 34.22 of FRS 102 regarding financial instruments that are measured in the balance sheet at fair value requires disclosure of fair value measurements dependent on whether the stock is quoted and the level of the accuracy in the ability to determine its fair value. The fair value measurement hierarchy is as follows: For Quoted Investments: Level a: quoted prices in active markets for an identical asset. The fair value of financial instruments traded in active markets is based on quoted market prices at the balance sheet date. A market is regarded as active if quoted prices are readily and regularly available, and those prices represent actual and regularly occurring market transactions on an arm's length basis. The quoted market price used for financial assets held is the bid price at the Balance Sheet date. Level b: where quoted prices are not available (or where a stock is normally quoted on a recognised stock exchange that no quoted price is available), the price of a recent transaction for an identical asset, providing there has been no significant change in economic circumstances or a significant lapse in time since the transaction took place. The Company holds no such investments in the current or prior year. For investments not quoted in an active market: Level c: the fair value of financial instruments that are not traded in an active market is determined by using valuation techniques. These valuation techniques maximise the use of observable data (eg the price of recent transactions, earnings multiple, discounted cash flows and/or net assets) where it is available and rely as little as possible on entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in level c (i). If one or more of the significant inputs is not based on observable market data, the instrument is included in level c (ii). There have been transfers between these classifications in the year when Castleton Technology (AIM listed) bought Impact Applications (unquoted), (2015: none). The change in fair value for the current and previous year is recognised in the income statement. Income Investment income includes interest earned on bank balances and from unquoted loan note securities, and dividends. Fixed returns on debt are recognised on a time apportionment basis so as to reflect the effective yield, provided it is probable that payment will be received in due course. Dividend income from investments is recognised when the shareholders' rights to receive payment have been established, normally the ex dividend date. Expenses All expenses are accounted for on an accruals basis. Expenses are charged wholly to revenue with the exception of the investment management fee which has been charged 75% to capital and 25% to revenue. (In 2015 the Investment Management fees were all charged to capital.) Any applicable performance fee will be charged 100% to capital. Revenue and capital The revenue column of the Income Statement includes all income and revenue expenses of the Company. The capital column includes gains and losses on disposal and holding gains and losses on investments. Gains and losses arising from changes in fair value of investments are recognised as part of the capital return within the Income Statement and allocated to the appropriate capital reserve on the basis of whether they are realised or unrealised at the balance sheet date. Taxation Current tax is recognised for the amount of income tax payable in respect of the taxable profit for the current or past reporting periods using the current tax rate. The tax effect of different items of income/gain and expenditure/loss is allocated between capital and revenue return on the "marginal" basis as recommended in the SORP. Deferred tax is recognised on an undiscounted basis in respect of all timing differences that have originated but not reversed at the balance sheet date, except as otherwise indicated. Deferred tax assets are only recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Financial instruments
The Company's principal financial assets are its investments and the policies in relation to those assets are set out above. Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. The Company does not have any externally imposed capital requirements. Reserves Called up equity share capital - represents the nominal value of shares that have been issued. Share premium account - includes any premiums received on issue of share capital. Any transaction costs associated with the issuing of shares are deducted from share premium. Unrealised capital reserve arises when the Company revalues the investments still held during the period and any gains or losses arising are credited/charged to the unrealised capital reserve. When an investment is sold any balance held on the unrealised capital reserve is transferred to the Profit and Loss Reserve as a movement in reserves. The Profit and Loss Reserve represents the aggregate of accumulated realised profits, less losses and dividends. Dividends Payable Dividends payable are recognised as distributions in the financial statements when the Company's liability to make payment has been established. This liability is established for interim dividends when they are declared by the Board, and for final dividends when they are approved by the Shareholders. 2. Income Year Ended Year Ended 29 February 2016 28 February 2015 GBP'000 GBP'000 Bank interest received - 1 Loan note interest received 4 7 Dividends received 90 - Total 94 8 3. Investment Management Fees Expenses are charged wholly to revenue with the exception of the investment management fee which has been charged 75% to capital in line with industry practice. In 2015, these fees were allocated all to capital. Year Ended Year Ended 29 February 2016 28 February 2015 GBP'000 GBP'000 Investment management fee 77 159 Total 77 159 In the year to 29 February 2016 the manager received a fee of 1% of the net asset value as at the previous year end (2015: 2%). Oxford Technology Management is also entitled to certain monitoring fees from investee companies and the Board monitors the amounts. Oxford Technology Management had previously agreed to defer 25% of the 2% management fee to which it was contractually entitled (ie 0.5% of net assets) until such a time when the finances of the Company made this payment more affordable. As part of the revised agreement with effect from 1 March 2015 the Board have agreed to pay the deferred balance over a 36 month period. A performance fee is payable to the Investment Manager once original shareholders have received a specified threshold in cash for each 100p (gross) invested. As reported in last year's accounts, the original threshold of 100p has now been increased by compounding that portion that remains to be paid to shareholders by 6% per annum with effect from 1 March 2015, resulting in the remaining required threshold rising to 67.7p at 29 February 2016, corresponding to a total shareholder return of 104.7p after taking into account the 37p already paid out (37p + 67.7p = 104.7p). After this amount has been distributed to shareholders, each extra 100p distributed goes 80p to the shareholder and 20p to the beneficiaries of the performance incentive fee, of which Oxford Technology Management receives 15p. No performance fee has become due or been paid to date. Any applicable performance fee will be charged 100% to capital. Expenses are capped at 3%, including the management fee but excluding Directors' fees and any performance fee. 4. Other Expenses All expenses are accounted for on an accruals basis. All expenses are charged through the income statement except as follows: -- those expenses which are incidental to the acquisition of an investment are included within the cost of the investment; -- expenses which are incidental to the disposal of an investment are deducted from the disposal proceeds of the investment. Year Ended Year Ended 29 February 2016 28 February 2015 GBP'000 GBP'000 Directors' remuneration 17 10 Auditors' remuneration 6 7 Legal and professional expenses 16 10 Accounting and administration services 5 4 Other expenses 11 15 Total 55 46 5. Tax on Ordinary Activities Corporation tax payable at 20% (2015: 21%) is applied to profits chargeable to corporation tax, if any. The corporation tax charge for the period was GBPnil (2015: GBPnil) Year Ended Year Ended 29 February 2016 28 February 2015 GBP'000 GBP'000 Return on ordinary activities before tax 2,366 (352) Current tax at standard rate of taxation 473 (74) Unrecognised tax losses (473) 74 Total current tax charge - - Unrelieved management expenses of GBP1,891,985 (2015: GBP1,760,814) remain available for offset against future taxable profits. 6. Earnings per Share The calculation of earnings per share (basic and diluted) for the period is based on the net profit of GBP2,366,000 (2015: loss of GBP352,000) attributable to shareholders divided by the weighted average number of shares 11,516,946 (2015: 11,516,946) in issue during the period. There are no potentially dilutive capital instruments in issue and, therefore, no diluted returns per share figures are relevant. The basic and diluted earnings per share are therefore identical. 7. Investments AIM quoted investments Unquoted investments Total Level a Level c(ii) investments GBP'000 GBP'000 GBP'000 Valuation and net book amount: Book cost as at 28 February 2015 42 6,919 6,961 Cumulative revaluation 58 (159) (101) Valuation at 28 February 2015 100 6,760 6,860 Movement in the year: Purchases at cost - 645 645 Disposals - costs (17) (1,569) (1,586) Disposals - revaluation (21) (633) (654) Transfer re Impact sale to Castleton 423 (423) - Revaluation in year 1,374 (19) 1,355 Valuation at 29 February 2016 1,859 4,760 6,619 Book cost at 29 February 2016 225 5,794 6,019 Cumulative revaluation to 29 February 2016 1,634 (1,034) 600 Valuation at 29 February 2016 1,859 4,760 6,619 Subsidiary Company The Company also holds 100% of the issued share capital of OT4 Managers Ltd at a cost of GBP1. Results of the subsidiary undertaking for the year ended 29 February 2016 are as follows: Country of Nature of Turnover Retained profit/loss Net Assets Registration Business OT4 England and Investment Managers Wales Manager GBP50,871 GBP0 GBP1 Ltd Consolidated group financial statements have not been prepared as the subsidiary undertaking is not considered to be material for the purpose of giving a true and fair view. The Financial Statements therefore present only the results of Oxford Technology 4 VCT plc, which the Directors also consider is the most useful presentation for Shareholders. 8. Debtors 29 February 2016 28 February 2015 GBP'000 GBP'000 Prepayments, accrued income & other debtors 2 2 Deferred consideration from sale of investments 24 156 Total 26 158 9. Creditors - amounts falling due in less than 1 year 29 February 2016 28 February 2015
GBP'000 GBP'000 Other creditors 9 16 Investment management fee accrual 27 27 Total 36 43 Creditors - amounts falling due in more than 1 year 29 February 2016 28 February 2015 GBP'000 GBP'000 Investment management fee accrual 27 53 Total 27 53 The Investment Manager has previously deferred 25% of fees, as detailed in Note 3. These are now being paid between March 2015 and February 2018. 10. Share Capital 29 February 2016 28 February 2015 GBP'000 GBP'000 Authorised: 15,000,000 ordinary shares of 10p each 1,500 1,500 Total Authorised 1,500 1,500 Allotted, called up and fully paid: 11,516,946 (2015: 11,516,946) ordinary shares of 10p each 1,152 1,152 11. Reserves When the Company revalues its investments during the period, any gains or losses arising are credited/charged to the Income Statement. Changes in fair value of investments are then transferred to the Unrealised Capital Reserve. When an investment is sold any balance held on the Unrealised Capital Reserve is transferred to the Profit and Loss Account Reserve as a movement in reserves. The transfer between the unrealised capital reserve and the profit and loss reserve is the result of the correction of historic misclassifications between the two reserves. The historic misclassifications are immaterial as they had no impact on reported returns or net assets and had no bearing on any distributions. Distributable reserves are GBP5,128,000 as at 29 February 2016. Reconciliation of Movement in Shareholders' Funds 29 February 2016 28 February 2015 GBP'000 GBP'000 Shareholders' funds at start of year 7,631 7,983 Return on ordinary activities after tax 2,366 (352) Dividends paid (2,304) - Shareholders' funds at end of year 7,693 7,631 The company paid a dividend of 10p per ordinary share on 7 August 2015 and a further dividend of 10p per share on 19 February 2016. 12. Financial Instruments and Risk Management The Company's financial instruments comprise equity and loan note investments, cash balances and debtors and creditors. The Company holds financial assets in accordance with its investment policy of investing mainly in a portfolio of VCT - qualifying quoted and unquoted securities whilst holding a proportion of its assets in cash or near cash investments in order to provide a reserve of liquidity. The risk faced by these instruments, such as interest rate risk or liquidity risk is considered to be minimal due to their nature. All of these are carried in the accounts at fair value. The Company's strategy for managing investment risk is determined with regard to the Company's investment objective. The management of market risk is part of the investment management process and is a central feature of venture capital investment. The Company's portfolio is managed with regard to the possible effects of adverse price movements and with the objective of maximising overall returns to shareholders. Investments in unquoted companies, by their nature, usually involve a higher degree of risk than investments in companies quoted on a recognised stock exchange, though the risk can be mitigated to a certain extent by diversifying the portfolio across business sectors and asset classes. The overall disposition of the Company's assets is regularly monitored by the Board. 13. Capital Commitments The company had no commitments at 29 February 2016 or 28 February 2015. 14. Related Party Transactions OT4 Managers Ltd, a wholly owned subsidiary, provides investment management services to the Company with effect from 1 July 2015 for a fee of 1% of net assets per annum. During the year, GBP50,871 was paid in respect of these fees. No amounts were outstanding at the year end. 15. Events after the Balance Sheet Date Naked Objects has been sold at the book value of GBP10,000 - March 2016. An additional investment of GBP98,000 has been made into ImmBio - March 2016. An additional investment of GBP200,000 has also been made into Plasma Antennas - April 2016. Company Number: 5038854 Note to the announcement: The financial information set out in this announcement does not constitute statutory accounts as defined in the Companies Act 2006 ("the Act"). The balance sheet as at 29 February 2016, income statement and cash flow statement for the period then ended have been extracted from the Company's 2016 statutory financial statements upon which the auditor's opinion is unqualified and does not include any statement under the section 495 of the Act. The Annual Report and Accounts for the year ended 29 February 2016 will be filed with the Registrar of Companies. Copies of the documents will be submitted to the National Storage Mechanism and are available for inspection at: http://www.mornningstar.co.uk/uk/NNSM This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Oxford Technology 4 VCT plc via Globenewswire HUG#2015609 http://www.oxfordtechnology.com
(END) Dow Jones Newswires
May 26, 2016 03:00 ET (07:00 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year Oxford Technology 4 Vent... Chart |
1 Month Oxford Technology 4 Vent... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions